Home/Pipeline/Papillon for Rectal Cancer

Papillon for Rectal Cancer

Early-stage and locally advanced rectal cancer

CommercialActive

Key Facts

Indication
Early-stage and locally advanced rectal cancer
Phase
Commercial
Status
Active
Company

About Ariane Medical Systems

Ariane Medical Systems, founded in 2009, is a private medical device company focused on advancing contact X-ray brachytherapy (CXB) for accessible tumors. Its core innovation is the Papillon+ system, featuring patented Micronode™ technology, which delivers high-dose radiation directly to tumors or surgical cavities in minutes. The company has achieved a significant milestone with a positive NICE recommendation for its rectal cancer treatment, positioning it for growth in organ-preserving oncology therapies. Ariane targets the clinical and economic benefits of shorter, more targeted radiotherapy procedures.

View full company profile